219 related articles for article (PubMed ID: 26654554)
1. [Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].
Manrique-Rodríguez S; Martín-Rabadán P; Díaz-Cámara M; Fernández-Llamazares CM
Med Clin (Barc); 2016 Apr; 146(8):376-7. PubMed ID: 26654554
[No Abstract] [Full Text] [Related]
2. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
[TBL] [Abstract][Full Text] [Related]
3. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.
Leung V; Al-Rawahi GN; Grant J; Fleckenstein L; Bowie W
Am J Trop Med Hyg; 2008 Dec; 79(6):853-5. PubMed ID: 19052292
[TBL] [Abstract][Full Text] [Related]
4. Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.
Moura EB; Maia Mde O; Ghazi M; Amorim FF; Pinhati HM
Braz J Infect Dis; 2012; 16(5):479-81. PubMed ID: 22975175
[TBL] [Abstract][Full Text] [Related]
5. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
Turner SA; Maclean JD; Fleckenstein L; Greenaway C
Am J Trop Med Hyg; 2005 Nov; 73(5):911-4. PubMed ID: 16282302
[TBL] [Abstract][Full Text] [Related]
6. Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.
Bogoch II; Khan K; Abrams H; Nott C; Leung E; Fleckenstein L; Keystone JS
Am J Trop Med Hyg; 2015 Jul; 93(1):94-6. PubMed ID: 25918215
[TBL] [Abstract][Full Text] [Related]
7. Non-oral treatment with ivermectin for disseminated strongyloidiasis.
Fusco DN; Downs JA; Satlin MJ; Pahuja M; Ramos L; Barie PS; Fleckenstein L; Murray HW
Am J Trop Med Hyg; 2010 Oct; 83(4):879-83. PubMed ID: 20889884
[TBL] [Abstract][Full Text] [Related]
8. Prompt diagnosis and treatment of strongyloidiasis in a renal transplant patient.
Briasoulis A; Psevdos G
South Med J; 2011 Jan; 104(1):72-3. PubMed ID: 21119560
[No Abstract] [Full Text] [Related]
9. Management of severe strongyloidiasis attended at reference centers in Spain.
Martinez-Perez A; Roure Díez S; Belhassen-Garcia M; Torrús-Tendero D; Perez-Arellano JL; Cabezas T; Soler C; Díaz-Menéndez M; Navarro M; Treviño B; Salvador F;
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006272. PubMed ID: 29474356
[TBL] [Abstract][Full Text] [Related]
10. Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient.
Benvenuti F; Carrascosa JM; Boada A; Ferrandiz C
Eur J Dermatol; 2009; 19(4):404-5. PubMed ID: 19467975
[No Abstract] [Full Text] [Related]
11. Strongyloides stercoralis in sputum.
Cheong CU; Gau SJ; Lai CC
QJM; 2014 Mar; 107(3):235-6. PubMed ID: 23708791
[No Abstract] [Full Text] [Related]
12. Decrease in eosinophilia as a marker of response to therapy in solid organ transplant candidates with Strongyloides infection: A single-center experience.
Simkins J; Anjan S; Camargo JF
Transpl Infect Dis; 2018 Oct; 20(5):e12954. PubMed ID: 29896920
[No Abstract] [Full Text] [Related]
13. Strongyloides stercoralis infection.
Greaves D; Coggle S; Pollard C; Aliyu SH; Moore EM
BMJ; 2013 Jul; 347():f4610. PubMed ID: 23900531
[No Abstract] [Full Text] [Related]
14. Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock.
Salluh JI; Feres GA; Velasco E; Holanda GS; Toscano L; Soares M
Intensive Care Med; 2005 Sep; 31(9):1292. PubMed ID: 16041520
[No Abstract] [Full Text] [Related]
15. Type 2 Diabetes Mellitus Is Associated with Strongyloides stercoralis Treatment Failure in Australian Aboriginals.
Hays R; Esterman A; McDermott R
PLoS Negl Trop Dis; 2015; 9(8):e0003976. PubMed ID: 26295162
[TBL] [Abstract][Full Text] [Related]
16. Dissemination: the fatal risk for a missed diagnosis of Strongyloides stercoralis infection.
Boscolo M; Bisoffi Z
J Infect; 2007 Sep; 55(3):284-5. PubMed ID: 17368549
[No Abstract] [Full Text] [Related]
17. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
Arch EL; Schaefer JT; Dahiya A
Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
[TBL] [Abstract][Full Text] [Related]
18. Acute strongyloidiasis in Italian tourists returning from Southeast Asia.
Angheben A; Mistretta M; Gobbo M; Bonafini S; Iacovazzi T; Sepe A; Gobbi F; Marocco S; Rossanese A; Bisoffi Z
J Travel Med; 2011; 18(2):138-40. PubMed ID: 21366799
[TBL] [Abstract][Full Text] [Related]
19. Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature.
Donadello K; Cristallini S; Taccone FS; Lorent S; Vincent JL; de Backer D; Jacobs F
Int J Antimicrob Agents; 2013 Dec; 42(6):580-3. PubMed ID: 24269075
[TBL] [Abstract][Full Text] [Related]
20. Management of Strongyloides stercoralis: a puzzling parasite.
Luvira V; Watthanakulpanich D; Pittisuttithum P
Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
